TY - JOUR
T1 - EURECCA colorectal: Multidisciplinary Mission statement on better care for patients with colon and rectal cancer in Europe
AU - van de Velde, Cornelis J. H.
AU - Aristei, Cynthia
AU - Boelens, Petra G.
AU - Beets-Tan, Regina G. H.
AU - Blomqvist, Lennart
AU - Borras, Josep M.
AU - van den Broek, Colette B. M.
AU - Brown, Gina
AU - Coebergh, Jan-Willem
AU - Van Cutsem, Eric
AU - Espin, Eloy
AU - Gore-Booth, Jola
AU - Glimelius, Bengt
AU - Haustermans, Karin
AU - Henning, Geoffrey
AU - Iversen, Lene H.
AU - van Krieken, J. Han
AU - Marijnen, Corrie A. M.
AU - Mroczkowski, Pawel
AU - Nagtegaal, Iris
AU - Naredi, Peter
AU - Ortiz, Hector
AU - Pahlman, Lars
AU - Quirke, Philip
AU - Roedel, Claus
AU - Roth, Alex
AU - Rutten, Harm J. T.
AU - Schmoll, Hans J.
AU - Smith, Jason
AU - Tanis, Pieter J.
AU - Taylor, Claire
AU - Wibe, Arne
AU - Gambacorta, Maria Antonietta
AU - Meldolesi, Elisa
AU - Wiggers, Theo
AU - Cervantes, Andres
AU - Valentini, Vincenzo
PY - 2013/9
Y1 - 2013/9
N2 - Background: Care for patients with colon and rectal cancer has improved in the last twenty years however still considerable variation exists in cancer management and outcome between European countries. Therefore, EURECCA, which is the acronym of European Registration of cancer care, is aiming at defining core treatment strategies and developing a European audit structure in order to improve the quality of care for all patients with colon and rectal cancer. In December 2012 the first multidisciplinary consensus conference about colon and rectum was held looking for multidisciplinary consensus. The expert panel consisted of representatives of European scientific organisations involved in cancer care of patients with colon and rectal cancer and representatives of national colorectal registries. Methods: The expert panel had delegates of the European Society of Surgical Oncology (ESSO), European Society for Radiotherapy & Oncology (ESTRO), European Society of Pathology (ESP), European Society for Medical Oncology (ESMO), European Society of Radiology (ESR), European Society of Coloproctology (ESCP), European CanCer Organisation (ECCO), European Oncology Nursing Society (EONS) and the European Colorectal Cancer Patient Organisation (EuropaColon), as well as delegates from national registries or audits. Experts commented and voted on the two web-based online voting rounds before the meeting (between 4th and 25th October and between the 20th November and 3rd December 2012) as well as one online round after the meeting (4th-20th March 2013) and were invited to lecture on the subjects during the meeting (13th-15th December 2012). The sentences in the consensus document were available during the meeting and a televoting round during the conference by all participants was performed. All sentences that were voted on are available on the EURECCA website www.canceraudit.eu. The consensus document was divided in sections describing evidence based algorithms of diagnostics, pathology, surgery, medical oncology, radiotherapy, and follow-up where applicable for treatment of colon cancer, rectal cancer and stage IV separately. Consensus was achieved using the Delphi method. Results: The total number of the voted sentences was 465. All chapters were voted on by at least 75% of the experts. Of the 465 sentences, 84% achieved large consensus, 6% achieved moderate consensus, and 7% resulted in minimum consensus. Only 3% was disagreed by more than 50% of the members. Conclusions: It is feasible to achieve European Consensus on key diagnostic and treatment issues using the Delphi method. This consensus embodies the expertise of professionals from all disciplines involved in the care for patients with colon and rectal cancer. Diagnostic and treatment algorithms were developed to implement the current evidence and to define core treatment guidance for multidisciplinary team management of colon and rectal cancer throughout Europe.
AB - Background: Care for patients with colon and rectal cancer has improved in the last twenty years however still considerable variation exists in cancer management and outcome between European countries. Therefore, EURECCA, which is the acronym of European Registration of cancer care, is aiming at defining core treatment strategies and developing a European audit structure in order to improve the quality of care for all patients with colon and rectal cancer. In December 2012 the first multidisciplinary consensus conference about colon and rectum was held looking for multidisciplinary consensus. The expert panel consisted of representatives of European scientific organisations involved in cancer care of patients with colon and rectal cancer and representatives of national colorectal registries. Methods: The expert panel had delegates of the European Society of Surgical Oncology (ESSO), European Society for Radiotherapy & Oncology (ESTRO), European Society of Pathology (ESP), European Society for Medical Oncology (ESMO), European Society of Radiology (ESR), European Society of Coloproctology (ESCP), European CanCer Organisation (ECCO), European Oncology Nursing Society (EONS) and the European Colorectal Cancer Patient Organisation (EuropaColon), as well as delegates from national registries or audits. Experts commented and voted on the two web-based online voting rounds before the meeting (between 4th and 25th October and between the 20th November and 3rd December 2012) as well as one online round after the meeting (4th-20th March 2013) and were invited to lecture on the subjects during the meeting (13th-15th December 2012). The sentences in the consensus document were available during the meeting and a televoting round during the conference by all participants was performed. All sentences that were voted on are available on the EURECCA website www.canceraudit.eu. The consensus document was divided in sections describing evidence based algorithms of diagnostics, pathology, surgery, medical oncology, radiotherapy, and follow-up where applicable for treatment of colon cancer, rectal cancer and stage IV separately. Consensus was achieved using the Delphi method. Results: The total number of the voted sentences was 465. All chapters were voted on by at least 75% of the experts. Of the 465 sentences, 84% achieved large consensus, 6% achieved moderate consensus, and 7% resulted in minimum consensus. Only 3% was disagreed by more than 50% of the members. Conclusions: It is feasible to achieve European Consensus on key diagnostic and treatment issues using the Delphi method. This consensus embodies the expertise of professionals from all disciplines involved in the care for patients with colon and rectal cancer. Diagnostic and treatment algorithms were developed to implement the current evidence and to define core treatment guidance for multidisciplinary team management of colon and rectal cancer throughout Europe.
KW - Quality assurance
KW - Multidisciplinary team
KW - Consensus
KW - Delphi method
KW - Audit
KW - Colon cancer
KW - Rectal cancer
KW - Neoadjuvant radiotherapy
KW - Neoadjuvant chemoradiotherapy
KW - Minimal invasive surgery
U2 - 10.1016/j.ejca.2013.04.032
DO - 10.1016/j.ejca.2013.04.032
M3 - Article
C2 - 23769991
SN - 0959-8049
VL - 49
SP - 2784
EP - 2790
JO - European Journal of Cancer
JF - European Journal of Cancer
IS - 13
ER -